Optimized Ultrasound-Assisted Extraction Enhances the Recovery of Anti-Collagenase Phytochemicals from Mitragyna speciosa Korth. Leaves
Plants · 07.08.2026 · 15 (16) · 2416
DOI: 10.3390/plants15162416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plants, online erschienen am 07.08.2026. Verfasst von Thasang Thavanapong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chiang Mai University.
Abstract (Originalsprache)
Mitragyna speciosa Korth. (Kratom) is a plant native to Southeast Asia, traditionally used for its stimulant and analgesic properties. Beyond mitragynine, the principal alkaloid dominating M. speciosa research, this study explored the cosmeceutical and nutraceutical potential of its phenolic and flavonoid constituents. Kratom leaf extract (MLE) was obtained via ultrasound-assisted extraction optimized by Central Composite Design, yielding high polyphenol content and antioxidant capacity. The optimized MLE showed measurable collagenase inhibition (IC50 = 92.63 ± 7.81 µg/mL) while maintaining fibroblast viability (>80%). UHPLC-ESI-QTOF-MS/MS tentatively identified chlorogenic acid, rutin, and kaempferol 3-glucosyl-(1→6)-galactoside (K3G). Chlorogenic acid and rutin were quantified by HPLC at 31.37 ± 2.41 and 18.76 ± 1.66 µg/mg extract, respectively, while K3G remained linked to an unidentified peak. Mitragynine was also quantified at an appreciable level (59.38 ± 0.21 µg/mg extract), indicating that removal of the alkaloid fraction is required before application. Molecular docking identified chlorogenic acid as the strongest predicted collagenase binder (−12.82 kcal/mol), though chlorogenic acid and rutin together could not fully account for the extract’s activity, suggesting possible contributions from K3G and other unidentified compounds. These findings provide preliminary evidence for the cosmeceutical potential of kratom leaf extract, pending control of its alkaloid content.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
- Doctoral Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
- School of Cosmetic Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.
- Green Cosmetic Technology Research Group, School of Cosmetic Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.
- Laboratory for Molecular Design and Simulation (LMDS), Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
- Innovation Center for Holistic Health, Nutraceuticals, and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
ORCID-Profile: Thasang Thavanapong, Nara Yaowiwat, Siripat Chaichit, Worrapan Poomanee
Förderung
- Chiang Mai University
Zitieren
APA
Thavanapong, T., Yaowiwat, N., Chaichit, S., Sainakham, M., Leelapornpisid, P., & Poomanee, W. (2026). Optimized Ultrasound-Assisted Extraction Enhances the Recovery of Anti-Collagenase Phytochemicals from Mitragyna speciosa Korth. Leaves. Plants, 15(16), 2416. https://doi.org/10.3390/plants15162416
Vancouver
Thavanapong T, Yaowiwat N, Chaichit S, Sainakham M, Leelapornpisid P, Poomanee W. Optimized Ultrasound-Assisted Extraction Enhances the Recovery of Anti-Collagenase Phytochemicals from Mitragyna speciosa Korth. Leaves. Plants. 2026;15(16):2416. doi:10.3390/plants15162416
BibTeX
@article{Thavanapong2026,
author = {Thavanapong, Thasang and Yaowiwat, Nara and Chaichit, Siripat and Sainakham, Mathukorn and Leelapornpisid, Pimporn and Poomanee, Worrapan},
title = {Optimized Ultrasound-Assisted Extraction Enhances the Recovery of Anti-Collagenase Phytochemicals from Mitragyna speciosa Korth. Leaves},
journal = {Plants},
year = {2026},
volume = {15},
number = {16},
pages = {2416},
doi = {10.3390/plants15162416}
}
EUVIMED